Lantern Pharma Inc (NAS:LTRN)
$ 3.27 -0.01 (-0.3%) Market Cap: 35.20 Mil Enterprise Value: 2.27 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 39/100

Q3 2021 Lantern Pharma Inc. Earnings Call Transcript

Nov 01, 2021 / 08:30PM GMT
Release Date Price: $10.1 (-1.08%)
Nicole Leber

Good afternoon, and welcome to Lantern Pharma's Third Quarter 2021 Earnings Call, being brought to you today as a Zoom webinar and conference call. As a reminder, this call is being recorded. (Operator Instructions) I am Nicole Leber with Finance and Administration at Lantern Pharma, and I will be your host for today's call. I will be joined by our CEO, CFO and CSO. (Operator Instructions). We will open the call for questions and answers after the presentation, which will be managed by our CEO, Panna Sharma, where he will be supported by our CSO, Kishor Bhatia, and our CFO, David Margrave. A press release was issued today after market close, with Lantern's third quarter 2021 financial results that management will be discussing during the call today as well as providing a corporate update.

Following the safe harbor statement, Panna will provide an overview of Lantern's business highlights, after which, David will overview Lantern's quarterly financial results, and Dr. Bhatia will provide an update on our R&D efforts. Panna will then offer concluding comments, after which we will answer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot